24 unknown. 24 Phase 2, 7 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 24 | Unknown 24 |
| Phase 1 | 7 | Unknown 7 |
| Phase 3 | 4 | Unknown 4 |
Follow Deglutition Disorders: new trials by email Literature Review of Deglutition Disorders trials Research Report on Deglutition Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer Epigallocatechin-3-gallate - Esophageal Cancer, Dysphagia, Esophageal | Phase 2 | Unknown | Shandong Cancer Hospital and Institute | 72 | 2024-04-22 | 2024-05-03 |
| Neuromuscular Electrical Stimulation for Children With Dysphagia VitalStim - Dysphagia | Phase 2 | Unknown | Sir Mortimer B. Davis - Jewish General Hospital | 10 | 2024-03-01 | 2024-03-13 |
| A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis Anaprazole sodium 40 mg, Anaprazole sodium 60 mg, Rabeprazole sodium 20 mg - Reflux Esophagitis, Gastroesophageal Reflux | Phase 2 | Unknown | Xuanzhu Biopharmaceutical Co., Ltd. | 156 | 2022-12-01 | 2022-11-03 |
| Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients Paclitaxel-albumin, Cisplatin, Carboplatin - Esophageal Squamous Cell Carcinoma, Patient-reported Outcomes | Phase 2 | Unknown | Guangdong Provincial People's Hospital | 50 | 2022-11-30 | 2022-11-28 |
| Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome Tongjiang granule, Tongjiang granule simulant - Gastroesophageal Reflux, Functional Dysphonia | Phase 1 / Phase 2 | Unknown | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 228 | 2022-03-26 | 2022-04-05 |
| Capsaicin for Post-stroke Dysphagia Capsaicin 1% oral solution, InOrpha Solution - Dysphagia, Late Effect of Stroke | Phase 2 | Unknown | Georg Kägi, MD | 82 | 2021-08-24 | 2023-06-22 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis | Phase 1 / Phase 2 | Unknown | All Natural Medicine Clinic, LLC | 2000 | 2021-03-01 | 2021-05-26 |
| Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia Saline Solution, Ceftazidime - Esophageal Achalasia | Phase 2 / Phase 3 | Unknown | Shanghai Zhongshan Hospital | 666 | 2017-10-01 | 2018-11-07 |
| Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease Treatment group, Control group - Non-erosive Reflux Disease | Phase 1 / Phase 2 | Unknown | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 204 | 2017-01-01 | 2019-08-26 |
| The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric Uncut Roux-en-Y Reconstruction, Billroth II Reconstruction - Gastric Cancer | Phase 2 | Unknown | Jilin University | 100 | 2016-02-01 | 2017-01-02 |
| Melanole, a Dietary Supplement, for the Treatment of Gastroesophageal Reflux Disease Melanole for GERD treatment, Placebo - GERD | Phase 2 / Phase 3 | Unknown | Lebanese American University | 170 | 2015-10-01 | 2015-10-28 |
| Lesogaberan in Chinese Patients With Refractory Reflux Symptoms Lesogaberan, Placebo - Gastroesophageal Reflux Disease | Phase 2 | Unknown | National Taiwan University Hospital | 72 | 2015-01-01 | 2016-06-29 |
| Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer Brachytherapy, Endoscopic stenting - Adenocarcinoma of the Esophago-gastric Junction | Phase 2 / Phase 3 | Unknown | Medical University of Lublin | 80 | 2013-02-01 | 2013-02-07 |
| A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers Codetron ALTENS - Head and Neck Cancer, Dysphagia | Phase 1 / Phase 2 | Unknown | McMaster University | 35 | 2012-10-01 | 2012-10-02 |
| The Effect of Repetitive Transcranial Magnetic Stimulation for Poststroke Dysphagia Recovery rTMS, Magstim Rapid2 - Stroke, Dysphagia | Phase 2 | Unknown | Taipei Veterans General Hospital, Taiwan | 50 | 2011-12-01 | 2014-03-18 |
| Endolumenal Partial Myotomy for Esophageal Motility Disorders Per oral endolumenal myotomy - Esophageal Motility Disorders | Phase 2 | Unknown | The Oregon Clinic | 20 | 2011-01-01 | 2011-02-28 |
| Endolumenal Partial Myotomy for the Treatment of Esophageal Achalasia Per oral endolumenal myotomy - Achalasia | Phase 2 | Unknown | The Oregon Clinic | 20 | 2010-10-01 | 2011-02-28 |
| Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders Per Oral Endoscopic Myotomy - Achalasia | Phase 2 | Unknown | Chinese University of Hong Kong | 20 | 2010-07-01 | 2012-02-02 |
| Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE. Secretol, Nexium - Gastroesophageal Reflux Disease (GERD), Heartburn | Phase 1 / Phase 2 | Unknown | Effexus Pharmaceutical | 40 | 2010-05-01 | 2014-08-05 |
| Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients 10 mg ilaprazole, 15 mg ilaprazole, 40 mg esomeprazole - Gastroesophageal Reflux Disease | Phase 2 | Unknown | Livzon Pharmaceutical Group Inc. | 330 | 2010-05-01 | 2010-04-21 |
Showing 20 of 24. Sign in to see all of them.
Gastroesophageal Reflux (10) · Esophageal Achalasia (4) · Esophageal Motility Disorders (2) · Heartburn (2) · Stroke (2) · Adenocarcinoma (1) · Ageusia (1) · Anosmia (1) · Anxiety Disorders (1) · Arthritis, Reactive (1) · Bipolar Disorder (1) · COVID-19 stress syndrome (1) · Depression (1) · Dyspepsia (1)
Digestive System Diseases (24) · Esophageal Diseases (23) · Gastrointestinal Diseases (23) · Esophageal Motility Disorders (14) · Otorhinolaryngologic Diseases (9) · Pharyngeal Diseases (9) · Neoplasms (5) · Neoplasms by Site (4) · Digestive System Neoplasms (3) · Gastrointestinal Neoplasms (3) · Nervous System Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Brain Diseases (2)
Esomeprazole (3) · Brachytherapy (1) · Capsaicin (1) · Carboplatin (1) · Ceftazidime (1) · Cisplatin (1) · Control Groups (1) · Esophagectomy (1) · Lansoprazole (1) · Melatonin (1) · Nigella sativa oil (1) · Omeprazole (1) · Rabeprazole (1) · Radiotherapy, Intensity-Modulated (1) · Saline Solution (1)
The Oregon Clinic (2) · Xiyuan Hospital of China Academy of Chinese Medical Sciences (2) · All Natural Medicine Clinic, LLC (1) · Chinese University of Hong Kong (1) · Effexus Pharmaceutical (1) · Federal University of São Paulo (1) · Georg Kägi, MD (1) · Guangdong Provincial People's Hospital (1) · Jilin University (1) · Lebanese American University (1) · Livzon Pharmaceutical Group Inc. (1) · McMaster University (1) · Medical University of Lublin (1) · National Taiwan University Hospital (1) · Rabin Medical Center (1)
China (7) · United States (5) · Taiwan (2) · Brazil (1) · Canada (1) · Hong Kong (1) · Israel (1) · Lebanon (1) · Poland (1) · Switzerland (1)
Ronnie Fass, MD (2) · Dariusz Kieszko, MD, PhD (1) · Grzegorz Wallner, Professor (1) · Guibin Qiao, MD (1) · Hani Dimassi, PhD (1) · Katia Alonso, PHD (1) · Krzysztof Zinkiewicz, MD, PhD (1) · Liya Zhou, MD (1) · Mohamad Mroueh, PhD (1) · Ping-Hong Zhou, MD, PhD (1) · Ping-Huei Tseng, MD, PhD (1) · Quan Wang, professor (1) · Raimond Wong, MD (1)